Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Natanie Faye Erlikh, M.D.

Concepts (16)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Insulin Antagonists12023200.230 Why?
Insulinoma120231240.220 Why?
Hypercalcemia120224090.180 Why?
End Stage Liver Disease120223140.160 Why?
Hypoglycemia120238610.140 Why?
Liver Diseases1202212530.120 Why?
Insulin1202365800.080 Why?
Pancreatic Neoplasms1202352560.070 Why?
Calcitonin120223360.050 Why?
Diphosphonates120226230.040 Why?
Sodium1202216230.040 Why?
Antibodies1202324600.030 Why?
Calcium1202257560.020 Why?
Severity of Illness Index12022155400.020 Why?
Retrospective Studies12022774490.010 Why?
Humans220237443430.010 Why?
Erlikh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (16)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.